Tag

Kestra Medical Technologies, Ltd.

1 article

Kestra Medical Reports Wider Q1 Loss

Kestra Medical posted adjusted loss of $0.75 per share for Q1 FY2027, versus $0.50 a year earlier. Revenue rose 60% YoY to $31.0 million, driven by wearable cardioverter defibrillator market expansion